Funding Rounds
Immunai Series A round February 2021
ImmunaiComprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
Summary
Stage: Series A
Raised Amount: $60.00M
Raised Date: 2021-02-01